We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STGW icon
2751
Stagwell
STGW
$2.16B
$191K ﹤0.01%
73,250
+24,316
+50% +$69.2K
IEA
2752
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$191K ﹤0.01%
23,279
+7,518
+48% +$68.9K
ORRF icon
2753
Orrstown Financial Services
ORRF
$852M
$189K ﹤0.01%
+10,366
New +$220K
ABUS icon
2754
Arbutus Biopharma
ABUS
$913M
$188K ﹤0.01%
49,032
+15,416
+46% +$75.9K
HSDT icon
2755
Solana Company
HSDT
$100M
0
QTRX icon
2756
Quanterix
QTRX
$177M
$186K ﹤0.01%
+10,151
New +$182K
USAP
2757
DELISTED
Universal Stainless & Alloy
USAP
$186K ﹤0.01%
+11,503
New +$233K
ACNT icon
2758
Ascent Industries
ACNT
$140M
$185K ﹤0.01%
+11,179
New +$201K
SBT
2759
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$184K ﹤0.01%
26,404
+10,025
+61% +$94.1K
CALA
2760
DELISTED
Calithera Biosciences, Inc
CALA
$182K ﹤0.01%
2,267
+681
+43% +$67.2K
RLH
2761
DELISTED
Red Lions Hotel Corporation
RLH
$182K ﹤0.01%
22,243
+6,875
+45% +$67.4K
SYRS
2762
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$181K ﹤0.01%
3,241
+1,100
+51% +$83.6K
AVID
2763
DELISTED
Avid Technology Inc
AVID
$180K ﹤0.01%
37,809
+10,957
+41% +$63.2K
FNKO icon
2764
Funko
FNKO
$314M
$178K ﹤0.01%
13,573
+4,539
+50% +$75.8K
PVLA
2765
Palvella Therapeutics
PVLA
$2.23B
$178K ﹤0.01%
835
+284
+52% +$88.1K
UPL
2766
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$178K ﹤0.01%
234,865
+64,730
+38% +$81.8K
PTN
2767
Palatin Technologies
PTN
$14.1M
$177K ﹤0.01%
200
+65
+48% +$67.7K
SMFG icon
2768
Sumitomo Mitsui Financial
SMFG
$161B
$177K ﹤0.01%
27,125
+327
+1% +$2.44K
VHC icon
2769
VirnetX Holding Corp
VHC
$63.9M
$177K ﹤0.01%
3,684
+1,166
+46% +$79.1K
GAIA icon
2770
Gaia
GAIA
$48.1M
$176K ﹤0.01%
16,994
+4,958
+41% +$65.4K
WATT icon
2771
Energous
WATT
$98.4M
$176K ﹤0.01%
51
+16
+46% +$78K
QHC
2772
DELISTED
Quorum Health Corporation
QHC
$176K ﹤0.01%
60,771
+11,556
+23% +$48.5K
DGICA icon
2773
Donegal Group Class A
DGICA
$729M
$174K ﹤0.01%
+12,788
New +$177K
FFNW
2774
DELISTED
First Financial Northwest, Inc
FFNW
$174K ﹤0.01%
+11,271
New +$172K
FSTX
2775
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$174K ﹤0.01%
4,193
+1,656
+65% +$74.5K

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.